FAQ

What is the focus of this program?

This graduate program offers advanced study in the disciplines essential to evaluating the relationship between pharmaceuticals, medical care, and health and economic outcomes. The field of pharmaceutical outcomes research is concerned with broader outcomes than simply the desired biological or physiological effects of pharmaceuticals, such as long-term morbidity, quality of life, and cost effectiveness. In addition, the need for better information about the economics and societal implications of drug therapy has fostered a growing interest in pharmaceutical policy research.

Does this program offer a Master’s degree?

This program does not have a terminal Master’s degree. Students are admitted into the PhD. program only. There is a combined PharmD/M.S. degree option for students currently enrolled in the UW School of Pharmacy’s PharmD program; in addition, physician (MD) scholars may apply for a MS degree with equivalent graduate course requirements to the PharmD/MS program, which can be completed in either one or two years. For more information please see the program description at Concurrent Degree Program.

Under rare instances we will consider terminal Master’s degree applications, provided there is room in the program, and there are available advisors. In such instances, the applicants must have at least 2 years full-time relevant work experience. There will be no funding provided by the program.

Is a PharmD degree required for admission?

No. Generally, a professional degree in pharmacy, medicine, or a health-related discipline is required. Students with Masters Degrees in related fields such as epidemiology, economics, or public health are also encouraged to apply.

What are the job opportunities for graduates of the program?

The job market for persons trained in this field is exceptionally strong, with increased funding and career opportunities related to comparative effectiveness research (CER). Our students are trained to take jobs in academic centers of excellence, the pharmaceutical or device industries, government agencies, research think tanks, and the managed care industry. The projection is that the field will continue to grow and that demand will remain high.

Please visit our Current and Alumni Graduate Students page to learn about the current positions of our program’s graduates.

How many students are accepted each year?

2-4 students per year. The size of the class is kept small so that each student has sufficient mentoring and interaction with faculty.

How are grades and GRE scores considered in the overall admissions evaluation?

Grade and GRE scores are one of several items considered by the admissions committee. For further information, please see Considerations for Evaluating Prospective Graduate Students.

Is financial support available?

We provide financial support to each entering student for up to two years through RAships, TAships, and research fellowships. After that, students are expected to seek their own scholarships, research assistantships or to compete for a limited number of endowed fellowships within the Department. Guidance is provided to locate external support.

What is the entry date into the program?

Because of the scheduling of core courses, students are accepted for Autumn quarter only. Autumn quarter typically begins the last week of September.

What is the application deadline?

December 31. Application review will begin the first week of January, and applicants will be notified of acceptance or rejection by March 30 at the latest.

What application materials are required?

See application information

I am not enrolled in a UW degree program. Can I still take the courses offered by your program?

With permission from the instructor, and on a space-available basis, graduate nonmatriculated students may enroll in courses offered by our program. For further information and enrollment procedures click here.